期刊文献+

氟伐他汀对高糖诱导人足细胞血管内皮生长因子表达的影响及机制 被引量:2

The effect and mechanism of fluvastatin on the expression of vascular endothelial growth factor in human podocytes induced by high glucose
原文传递
导出
摘要 目的探讨氟伐他汀对高糖诱导的人足细胞血管内皮生长因子(VEGF)表达的影响及机制。方法体外培养人足细胞,随机分为A组(正常糖组)、B组(高糖组)、C组(高糖+氟伐他汀10-7mol/L组)、D组(高糖+氟伐他汀10-6mol/L组)、E组(高糖+氟伐他汀10-5mol/L组)和F组[高糖+胞外信号调节激酶(ERK)抑制剂PD98059组]。用Western blot检测VEGF和磷酸化ERK1/2(pERK1/2)蛋白表达。结果 B组VEGF、pERK1/2表达较A组明显升高,并呈时间依赖性(P<0.05)。F组VEGF、pERK1/2表达较B组显著降低(P<0.01)。与B组比较,C、D、E组VEGF及pERK1/2表达亦明显减少,并呈浓度依赖性(P<0.05)。结论高糖刺激体外培养人足细胞VEGF表达增加,氟伐他汀可减少高糖诱导的VEGF表达,其机制可能与氟伐他汀抑制ERK信号通路有关。 Objective To investigate the effect and mechanism of fluvastatin on the expression of vascular endothelial growth factor(VEGF) in human podocytes induced by high glucose.MethodsHuman podocytes were randomly divided into six groups of A (normal glucose),B(high glucose),C(high glucose plus fluvastatin 10^-7mol/L),D(high glucose plus fluvastatin 10^-6mol/L),E(high glucose plus fluvastatin 10^-5mol/L) and F[high glucose plus extracellular signal-regulated kinase(ERK) inhibitor PD98059].The expressions of VEGF and phospho-ERK1/2(pERK1/2) were detected by Western blot.Results The expressions of VEGF and pERK1/2 in group B were increased time-dependently and higher than those in groups of A,C,D,E and F(P〈0.05 or P〈0.01).Conclusion High glucose increases VEGF expression in human podocytes,which can be decreased by fluvastatin treatment through inhibiting the signaling pathway of ERK.
出处 《江苏医药》 CAS CSCD 北大核心 2011年第15期1740-1742,I0001,共4页 Jiangsu Medical Journal
基金 江苏省卫生厅科研基金(H200317)
关键词 氟伐他汀 高糖 足细胞 血管内皮生长因子 胞外信号调节激酶信号通路 Fluvastatin High glucose Podocyte Vascular endothelial growth factor Extracellular signal-regulated kinase signal pathway
  • 相关文献

参考文献7

  • 1Cha DR,Kang YS, Han SY,et al. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type lI diabetic rats[J].J Endocrinol, 2004,183(1) : 183-194.
  • 2Jefferson JA,Shankland SJ,Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint[J]. Kidney Int, 2008, 74(1) : 22-36.
  • 3Mantuano E, Santi S, Filippi C, et al. Simvastatin and fluvas-tatin reduce interleukin-6 and interleukin-8 lipopolysaceharide (LPS) stimulated production by isolated human monocytes from chronic kidney disease patients[J]. Biomed Pharmacother, 2007,61(6) :360-365.
  • 4Naito M, Shenoy A, Aoyama I, et al. High ambient glucose augments angiotensin 11 -induced proinflammatory gene mRNA expression in human mesangial cells., effects of valsartan and simvastatin[J]. Am J Nephrol, 2009,30 (2) : 99-111.
  • 5Sehrijvers BF,Flyvbjerg A,De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology [J].Kidney Int,2004,65(6):2003-2017.
  • 6潘珺,黄智敏,赵秀芬,钱军,毛慧娟,刘佳,孙彬,邢昌赢.水飞蓟宾对高糖诱导人足细胞中VEGF表达的影响[J].江苏医药,2010,36(10):1124-1127. 被引量:6
  • 7Yokota T, Utsunomiya K, Murakawa Y, et al. Mechanism of preventive effect of HMG-CoA reductase inhibitor on diabetic nephropathy[J]. Kidney Int, 1999, 56(Suppl 71) :178-181.

二级参考文献13

  • 1葛勇,张家庆,周云平.水飞蓟宾及槲皮素对体外白蛋白非酶糖化的抑制作用[J].第二军医大学学报,1995,16(4):333-336. 被引量:33
  • 2Li JJ, Kwak SJ, Jung DS, et al. Podocyte biology in diabetic nephropathy[J].Kidney Int, 2007,106 :S36-S42.
  • 3Huseini HF, Larijani B, Heshmat R, et al. The efficacy of silybum marianum (L.) Gaertrn.(silymarin) in the treatment of type Ⅱ diabetes: a randomized, double-blind, placebo-controlled, clinical trial[J].Phytother Res, 2006,20( 125 : 1036- 1039.
  • 4Kim S, Choi JH, Lim HI, et al. Silibinin prevents TPA-induced MMP-9 expression and VEGF seeretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells[J].Phytomedicine, 2009,16(6) : 573-580.
  • 5Foster RR, Hole R, Anderson K, et al. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes [J]. Am J Physiol Renal Physiol,2003,284(6) :F1263-1273.
  • 6Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, et al. Effects of high glucose and TGF-β1 on the expression of collagen Ⅳ and vascular endothelial growth factor in mouse podocytes[J]. Kidney Int,2002, 62(3) :901-913.
  • 7Chen S, Kasama Y, Lee JS, et al. Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3 (Ⅳ) collagen production by transforming growth factor-betal in mouse podocytes[J]. Diabetes, 2004,53 (11) : 2939-2949.
  • 8Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology[J].Kidney Int,2004,65(6):2003-2017.
  • 9Hoshi S, Nomoto K, Kuromitsu J, et al. High glucose induced VEGF expression via PKC and ERK in glomerular podocytes[J].Bioehem Biophys Res Commun, 2002,290 (1) : 177-184.
  • 10Zhao J, Agarwal R. Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase Ⅱ enzymes: implications in cancer chemoprevention[J].Carcinogenesis, 1999, 20 (11) : 2101- 2108.

共引文献5

同被引文献30

  • 1李铎,邹和群,黎敏,RastaldiMariaPia,DAmicoGinseppe.H-2K^b-tsA58转基因小鼠肾小球内皮和足细胞株的分离培养与鉴定[J].中国临床医学,2006,13(3):459-462. 被引量:3
  • 2曾莉,黄颂敏,蔡文利,付平,周莉.罗格列酮对高糖刺激的大鼠肾小球系膜细胞B_1整合素、ICAM-1表达的影响[J].四川大学学报(医学版),2006,37(4):599-601. 被引量:4
  • 3赵景宏,黄岚,王军平,晋军,宋耀明,方玉强,崔斌,于世勇.大鼠肾小球内皮细胞培养及高糖对其分泌NO的影响[J].免疫学杂志,2007,23(1):13-15. 被引量:4
  • 4Reddy GR, Kotlyarevska K, Ransom RF, etal. The podocyte and diabetes mellitus: is the podoeyte the key to the origins of diabetic nephropathy[J]? Curr Opin Nephrol Hypertens, 2008,17(1) : 32-36.
  • 5Jefferson JA, Shankland SJ, Piehler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint [J]. Kidney Int,2008,74(1) :22-36.
  • 6Mantuano E, Santi S, Filippi C, et al. Simvastatin and fluvastatin reduce interleukin-6 and interleukin-8 lipopolysaccharide(LPS) stimulated production by isolated human monocytes from chronic kidney disease patients[J]. Biomed Pharmaeother, 2007,61 (6) : 360-365.
  • 7Steffes MW, Schmidt D, McCrery R, et aI. Glomerular cell number in normal subjects and in type 1 diabetic patients[J]. Kidney Int, 2001,59(6) :.2104-2113.
  • 8Susztak K, Raft AC, Sehiffer M, et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy[J]. Diabetes, 2006,55 (1) : 225-233.
  • 9Brownlee M. Biochemistry and molecular cell biology of diabetic complications[J]. Nature, 2001,414(6865) : 813-820.
  • 10Kim NH, Rincon-Choles H, Bhandari B, et al. Redox dependence of glomerular epithelial cell hypertrophy in response to glucose[J]. Am J Physiol Renal Physiol, 2006, 290(3) : 741-751.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部